Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial.
Tang Y, Chen J, Liu Q, Chu T, Pan T, Liang J, He XF, Chen F, Yang T, Ma X, Wu X, Hu S, Cao X, Hu X, Hu J, Liu Y, Qi J, Shen Y, Ruan C, Han Y, Wu D.
Tang Y, et al.
Blood Adv. 2021 Mar 9;5(5):1250-1258. doi: 10.1182/bloodadvances.2020002790.
Blood Adv. 2021.
PMID: 33646303
Free PMC article.
Clinical Trial.